The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
Tag: Amylyx Pharmaceuticals Inc
-
New Experimental Therapy for A.L.S. Approved in Canada
The F.D.A. is also reviewing the treatment, Albrioza, but the agency’s scientists have raised questions about its effectiveness.